Evidence-Based Prioritization and Scoring of Genomic Loci Interacting With Pioglitazone Therapeutic Response in Diabetic Patients. Precis. Med. Com. 2022, 2 (2), 91-108. https://doi.org/10.55627/pmc.002.02.0188.